Meeder Asset Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-270
| Closed | -$1K | – | 2496 |
|
|
2021
Q1 | $1K | Buy |
+270
| New | +$1K | ﹤0.01% | 2166 |
|
|
2020
Q3 | – | Sell |
-10,276
| Closed | -$139K | – | 2151 |
|
|
2020
Q2 | $139K | Buy |
10,276
+4,885
| +91% | +$66.1K | 0.01% | 685 |
|
|
2020
Q1 | $42K | Buy |
5,391
+650
| +14% | +$5.06K | ﹤0.01% | 972 |
|
|
2019
Q4 | $30K | Buy |
4,741
+3,308
| +231% | +$20.9K | ﹤0.01% | 1208 |
|
|
2019
Q3 | $6K | Sell |
1,433
-2,281
| -61% | -$9.55K | ﹤0.01% | 1685 |
|
|
2019
Q2 | $18K | Buy |
+3,714
| New | +$18K | ﹤0.01% | 1267 |
|
|
2019
Q1 | – | Sell |
-3,308
| Closed | -$19K | – | 1690 |
|
|
2018
Q4 | $19K | Buy |
3,308
+2,504
| +311% | +$14.4K | ﹤0.01% | 1074 |
|
|
2018
Q3 | $7K | Sell |
804
-15
| -2% | -$131 | ﹤0.01% | 1234 |
|
|
2018
Q2 | $8.17K | Buy |
819
+739
| +924% | +$7.38K | ﹤0.01% | 1160 |
|
|
2018
Q1 | $1K | Sell |
80
-140
| -64% | -$1.75K | ﹤0.01% | 1439 |
|
|
2017
Q4 | $3K | Buy |
+220
| New | +$3K | ﹤0.01% | 1414 |
|
|
2017
Q3 | – | Sell |
-317
| Closed | -$5K | – | 1618 |
|
|
2017
Q2 | $5K | Sell |
317
-357
| -53% | -$5.63K | ﹤0.01% | 1180 |
|
|
2017
Q1 | $6K | Buy |
674
+452
| +204% | +$4.02K | ﹤0.01% | 989 |
|
|
2016
Q4 | $2K | Buy |
+222
| New | +$2K | ﹤0.01% | 927 |
|